- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC in the Press, November 18, 2016
A review of our peer-reviewed research in the healthcare and mainstream press.
MIT News cited an August study from The American Journal of Managed Care (AJMC) in an article about data-driven diabetes management. The AJMC study, “Association Among Change in Medical Costs, Level of Comorbidity, and Change in Adherence Behavior,” examined the costs of medication nonadherence for patients with diabetes and other conditions. A formerly nonadherent patient becoming adherent is associated with significant savings, which is why the MIT article is enthusiastic about a smart insulin-pen cap that sends usage data to an app.
An article about pain relievers in The Washington Post mentioned a 2013 AJMC study, “Quantifying the Impact of NSAID-Associated Adverse Events.” The Post article cited the study’s finding that half of seniors 65 years or older take at least 7 doses of nonsteroidal anti-inflammatory drugs (NSAIDs) per week.
Bridging the Vaccination Gap: Insights on Global Immunization Challenges
July 30th 2024On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
Listen
Despite Record ACA Enrollment, Report Reveals Underinsured Americans Are in Crisis
November 21st 2024Despite significant progress in expanding health insurance coverage since the Affordable Care Act (ACA) was enacted, millions of Americans still face critical gaps in access to and affordability of health care.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes
November 19th 2024Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Read More
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
